Distribution of serum FLC and kappa/lambda ratio in patients with renal... | Download Table
Manni Mohyuddin on Twitter: "Well- Normally kappa FLC are produced more often than lambda.. BUT lambda more frequently forms dimers, which doubles their molecular weight and slows their renal clearance..." / Twitter
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease | American Society of Nephrology
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients - ScienceDirect
Evolution of kappa, lambda light chain level and kappa/lambda ratio (A)... | Download Scientific Diagram
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Multiple myeloma: Diagnosis and management issues in patients with pre-existing chronic kidney disease
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
PDF) The renal range of the κ/λ sFLC ratio: Best strategy to evaluate multiple myeloma in patients with chronic kidney disease
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - ScienceDirect
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure | BMC Nephrology | Full Text
Providence Health Care Test Catalog
